Raymond James Financial Aktie
| 158,77USD | 0,10USD | 0,06% |
WKN: 875072 / ISIN: US7547301090
Personal
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 20 021 | 22 043 | 23 019 | 23 961 | 0 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,49 | 0,51 | 0,57 | 0,62 | 0,00 |
Bilanz (in Mio. USD) - Aktiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 23 596 | 21 355 | 18 495 | 21 333 | 0 |
| Summe Anlagevermögen | 38 560 | 59 596 | 59 865 | 61 659 | 0 |
| Summe Aktiva | 62 156 | 80 951 | 78 360 | 82 992 | 88 200 |
Bilanz (in Mio. USD) - Passiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 53 853 | 71 519 | 68 173 | 71 325 | 0 |
| Summe Eigenkapital | 8 303 | 9 432 | 10 187 | 11 667 | 12 400 |
| Summe Passiva | 62 156 | 80 951 | 78 360 | 82 992 | 0 |
Adresse
| 880 Carillon Parkway, 33716 St. Petersburg | |
| Telefon | +1 (727) 567-1000 |
| Internet | http://www.raymondjames.com |
Management
|
Andy Zolper
Chief Information Technology Security Officer |
|
Anne Gates
Independent Non-Executive Director |
|
Art A. Garcia
Independent Non-Executive Director |
|
Bella Loykhter Allaire
Chief Administrative Officer |
|
Benjamin C. Esty
Independent Non-Executive Director |
|
Bradley Ward Sussman
VP-Alternative Investments Product Development |
|
Calvin Sullivan
Chief Strategy Officer-Fixed Income Division |
|
Cecily Mistarz
Independent Non-Executive Director |
|
Chad Runnels
Senior Vice President |
|
Christopher S. Aisenbrey
Chief Human Resources Officer |
|
Chuck Ellingsworth
Managing Director |
|
David De Luca
Senior Managing Director & Head-Global Equities |
|
David Krauss
Chief Risk Officer |
|
Doug Brigman
Chief Administrative Officer-Asset Management |
|
Gavin Murrey
Executive Vice President & Head-Public Finance |
|
Gordon L. Johnson
Independent Non-Executive Director |
|
Guy Logan
Managing Director-Atlanta Region |
|
Horace Carter
President-Fixed Income |
|
Jack A. Dudick
MD-Healthcare Finance Gp, Head-Healthcare Real Est |
|
James E. Bunn
President-Capital Markets |
|
Jay Hernandez
Managing Director-Boston |
|
Jeffrey N. Edwards
Lead Independent Non-Executive Director |
|
Jonathan N. Santelli
Secretary, Executive VP & General Counsel |
|
Jonathan W. Oorlog
Chief Financial Officer |
|
K. Gregory Rust
Senior Vice President-Operations |
|
Katherine H. Larson
Chief Accounting Officer |
|
Kevin J. Kooman
Managing Director-Investment Banking |
|
Kristina R. Waugh
Senior Vice President-Investor Relations |
|
Leslie Ann Brooks Curry
Chief Experience Officer-Investment Banking |
|
Mark W. Begor
Director |
|
Marlene B. Debel
Independent Non-Executive Director |
|
Mike White
Chief Marketing Officer |
|
Parker Colvin
Managing Director |
|
Paul C. Reilly
Executive Chairman |
|
Paul M. Shoukry
President, Chief Executive Officer & Director |
|
Raj Seshadri
Independent Non-Executive Director |
|
Raymond W. McDaniel
Independent Non-Executive Director |
|
Roderick C. McGeary
Independent Non-Executive Director |
|
Scott Alan Curtis
Chief Operating Officer |
|
Steve LaBarbera
Chief Compliance Officer |
|
Stuart Barich
Managing Dir-Life Sciences Investment Banking Team |
|
Stuart Feld
Chief Artificial Intelligence Officer |
|
TJ Haynes-Morgan
Chief Audit Executive |
|
Tarek Helal
Chief Strategy Officer |
|
Tashtego Spring Elwyn
President-Private Client Group |
|
Vin Campagnoli
Executive Vice President-Technology & Operations |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.